Literature DB >> 9406329

Contributions of the pedunculopontine region to normal and altered REM sleep.

D B Rye1.   

Abstract

The pedunculopontine (PPN) region of the upper brainstem is recognized as a critical modulator of activated behavioral states such as wakefulness and rapid eye movement (REM) sleep. The expression of REM sleep-related physiology (e.g. thalamocortical arousal, ponto-geniculate-occipital (PGO) waves, and atonia) depends upon a subpopulation of PPN neurons that release acetylcholine (ACh) to act upon muscarinic receptors (mAChRs). Serotonin's potent hyperpolarization of cholinergic PPN neurons is central to present working models of REM sleep control. A growing body of experimental evidence and clinical experience suggests that the responsiveness of the PPN region, and thereby modulation of REM sleep, involves closely adjacent glutamatergic neurons and alternate afferent neurotransmitters. Although many of these afferents are yet to be defined, dopamine-sensitive GABAergic pathways exiting the main output nuclei of the basal ganglia and adjacent forebrain nuclei appear to be the most conspicuous and the most likely to be clinically relevant. These GABAergic pathways are ideally sited to modulate the physiologic hallmarks of REM sleep differentially (e.g. atonia versus cortical activation), because each originates from a functionally unique forebrain circuit and terminates in a unique pattern upon brain stem neurons with unique membrane characteristics. Evidence is reviewed that changes in the quality, timing, and quantity of REM sleep that characterize narcolepsy, REM sleep behavior disorder, and neurodegenerative and affective disorders (depression and schizophrenia) reflect 1) changes in responsiveness of cells in the PPN region governed by these afferents; 2) increase or decrease in PPN cell number; or 3) mAChRs mediating increased responsiveness to ACh derived from the PPN. Auditory evoked potentials and acoustic startle responses provide means independent from recording sleep to assess pathophysiologies affecting the PPN and its connections and thereby complement investigations of their role in affecting daytime functions (e.g. arousal and attention).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406329     DOI: 10.1093/sleep/20.9.757

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  68 in total

Review 1.  Role of norepinephrine in the regulation of rapid eye movement sleep.

Authors:  Birendra N Mallick; Sudipta Majumdar; Mohd Faisal; Vikas Yadav; Vibha Madan; Dinesh Pal
Journal:  J Biosci       Date:  2002-09       Impact factor: 1.826

2.  Cholinergic cells in the tegmentum send branching projections to the inferior colliculus and the medial geniculate body.

Authors:  S D Motts; B R Schofield
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

3.  The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered.

Authors:  Mingchu Xi; Michael H Chase
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

Review 4.  Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.

Authors:  C Karachi; Chantal Francois
Journal:  J Neural Transm (Vienna)       Date:  2017-01-13       Impact factor: 3.575

5.  Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?

Authors:  Christian Baumann; Luigi Ferini-Strambi; Daniel Waldvogel; Esther Werth; Claudio Lino Bassetti
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

6.  GABAergic modulation of developing pedunculopontine nucleus.

Authors:  Kevin D Bay; Paige Beck; Robert D Skinner; Edgar Garcia-Rill
Journal:  Neuroreport       Date:  2007-02-12       Impact factor: 1.837

7.  Injection of glutamate into the pedunculopontine tegmental nuclei of anesthetized rat causes respiratory dysrhythmia and alters EEG and EMG power.

Authors:  Jasna Saponjic; Miodrag Radulovacki; David W Carley
Journal:  Sleep Breath       Date:  2005-06       Impact factor: 2.816

8.  Morphological differences in Parkinson's disease with and without rest tremor.

Authors:  David H Benninger; Sebastian Thees; Spyros S Kollias; Claudio L Bassetti; Daniel Waldvogel
Journal:  J Neurol       Date:  2009-02-04       Impact factor: 4.849

9.  Elevated PEM (phasic electromyographic metric) rates identify rapid eye movement behavior disorder patients on nights without behavioral abnormalities.

Authors:  Donald L Bliwise; David B Rye
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

Review 10.  Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes.

Authors:  Olivier George; Monique Vallée; Michel Le Moal; Willy Mayo
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.